Literature DB >> 8564526

Release of sulfidoleukotrienes in vitro: its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid.

W Czech1, E Schöpf, A Kapp.   

Abstract

Pseudo-allergic reactions (PAR) are caused by a variety of drugs, of particular interest by acetylsalicylic acid (ASA) and other nonsteroidal antiinflammatory drugs. The clinical symptoms often resemble immediate type hypersensitivity reactions and consist of bronchospasm, urticaria, angioedema and even anaphylactic shock. Antigen specific immune mechanisms, however, are not involved. In general, skin tests are not reliable and the diagnosis of PAR is based mainly on risky provocation tests. Therefore, the purpose of this study was to establish procedures for in vitro diagnosis of PAR to ASA. A controlled study was performed including patients with PAR to ASA based on history and positive oral provocation test and non-atopic as well as atopic controls. In this in vitro study the production of sulfidoleukotrienes (sLT) by isolated leukocytes was measured by cellular allergen stimulation test (CAST), which is based on detection of LTC4, LTD4 and LTE4 by a monoclonal antibody. Accordingly, the direct effect of ASA as well as the modulatory effect of ASA on C5a-induced production of sLT in leukocytes in vitro was investigated. In patients with PAR to ASA, C5a-induced generation of sLT was significantly increased as compared to normal controls. In contrast, there was no difference in the spontaneous release of sLT in vitro in patients and controls. Preincubation of leukocytes with ASA did not exert a significant modulatory effect on the spontaneous or the C5a-induced production of sLT in patients and controls. In summary, the present study provides a novel in vitro test system for the diagnosis of PAR to ASA by measurement of sLT release in leukocytes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564526     DOI: 10.1007/bf02032571

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  22 in total

1.  Tryptase and histamine release during aspirin-induced respiratory reactions.

Authors:  J V Bosso; L B Schwartz; D D Stevenson
Journal:  J Allergy Clin Immunol       Date:  1991-12       Impact factor: 10.793

2.  Concerning the nature of intolerance to aspirin.

Authors:  M Samter; R F Beers
Journal:  J Allergy       Date:  1967-11

3.  Asthma and anti-inflammatory drugs. Mechanisms and clinical patterns.

Authors:  A Szczeklik; R J Gryglewski
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

4.  Basophil histamine release by platelet-activating factor in aspirin-sensitive subjects with asthma.

Authors:  Y Okuda; H Hattori; T Takashima; A Miyatake; A Yamatodani; I Tsuyuguchi; S Kishimoto
Journal:  J Allergy Clin Immunol       Date:  1990-10       Impact factor: 10.793

5.  The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation.

Authors:  Y Kurimoto; A L De Weck; C A Dahinden
Journal:  Eur J Immunol       Date:  1991-02       Impact factor: 5.532

6.  Histaminemia after aspirin challenge in aspirin-sensitive asthmatics.

Authors:  M Szmidt; I Grzelewska-Rzymowska; J Rozniecki; M L Kowalski; I Rychlicka
Journal:  Agents Actions       Date:  1981-04

7.  Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs.

Authors:  D D Stevenson
Journal:  J Allergy Clin Immunol       Date:  1984-10       Impact factor: 10.793

8.  Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge.

Authors:  U R Juergens; S C Christiansen; D D Stevenson; B L Zuraw
Journal:  J Allergy Clin Immunol       Date:  1992-10       Impact factor: 10.793

9.  Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects.

Authors:  P E Christie; P Tagari; A W Ford-Hutchinson; S Charlesson; P Chee; J P Arm; T H Lee
Journal:  Am Rev Respir Dis       Date:  1991-05

10.  Effect of aspirin on the complement system in vitro.

Authors:  G M Hänsch; V Voigtländer; U Rother
Journal:  Int Arch Allergy Appl Immunol       Date:  1980
View more
  7 in total

1.  Aspirin induced adverse skin reactions: new pathophysiological aspects.

Authors:  B Wedi; A Kapp
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  [Cellular in-vitro assays. Applicability in daily routine].

Authors:  B Wedi; A Kapp
Journal:  Hautarzt       Date:  2010-11       Impact factor: 0.751

3.  Unreliable measurement of basophil maximum leukotriene release with the Bühlmann CAST 2000 enzyme-linked immunosorbent assay kit.

Authors:  S E Burastero; C Paolucci; D Breda; G Monasterolo; R E Rossi; L Vangelista
Journal:  Clin Vaccine Immunol       Date:  2006-03

4.  C5a-induced in vitro basophil activation in patients with chronic urticaria: a pilot study.

Authors:  Peter Korosec; Tjasa Subic; Katja Adamic; Mira Silar; Mitja Kosnik
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 5.  [Basophil activation tests in the diagnosis of drug reactions].

Authors:  S M Erdmann; S Ventocilla; S Moll-Slodowy; I Sauer; H F Merk
Journal:  Hautarzt       Date:  2005-01       Impact factor: 0.751

Review 6.  Cellular in vitro diagnosis of adverse drug reactions.

Authors:  Christian Möbs; Wolfgang Pfützner
Journal:  Allergo J Int       Date:  2014-08-07

Review 7.  Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?

Authors:  David Spoerl; Haig Nigolian; Christoph Czarnetzki; Thomas Harr
Journal:  Int J Mol Sci       Date:  2017-06-07       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.